Survivin and MK167 mRNA expression in bladder washings of patients with superficial urothelial cell carcinoma correlate with tumor stage and grade but do not predict tumor recurrence [10]

Clinical Chemistry

Volumn 52, Issue 7, 2006, Pages 1440-1442

  Schultz, Iman J ^a   Kiemeney, Lambertus A ^a   Willems, Johannes L ^a   Swinkels, Dorine W ^a   Witjes, J Alfred ^a   De Kok, Jacques B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; MONOCLONAL ANTIBODY KI 67; SURVIVIN; BIRC5 PROTEIN, HUMAN; KI 67 ANTIGEN; MICROTUBULE ASSOCIATED PROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; FEMALE; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; MALE; MK167 GENE; PREDICTION; PROTEIN EXPRESSION; SUPERFICIAL CANCER; UROGENITAL TRACT CANCER; UROTHELIUM; BIOSYNTHESIS; BLADDER; BLADDER TUMOR; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; TRANSITIONAL CELL CARCINOMA; TUMOR RECURRENCE;

AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 33745457689     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.071480     Document Type: Letter

References (8)

1. Pich A, Chiusa L, Fortniconi A, Galliano D, Bortolin P, Comino A, et al. Proliferative activity is the most significant predictor of recurrence in non-invasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder. Cancer 2002;95:784-90.
2. Santos L, Amaro T, Costa C, Pereira S, Bento MJ, Lopes P, et al. Ki-67 index enhances the prognostic accuracy of the urothelial superficial bladder carcinoma risk group classification. Int J Cancer 2003;105:267-72.
3. Schultz IJ, Kiemeney LA, Witjes JA, Schalken JA, Willems JL, Swinkels DW, et al. Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence. Anticancer Res 2003;23:3327-31.
4. Weikert S, Christoph F, Schrader M, Krause H, Miller K, Muller M. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis, Int J Cancer 2005;116:100-4.
5. Schultz IJ, Kiemeney LA, Karthaus HF, Witjes JA, Willems JL, Swinkels DW, et al. Survivin mRNA copy number in bladder washings predicts tumor recurrence in patients with superficial urothelial cell carcinomas. Clin Chem 2004;50:1425-8.
6. Acar H, Kilinc M, Yildirim MS, Kaynak M, Cenker A. Evaluation of chromosome 8 and 11 aneuploidies in washings and biopsy materials of bladder transitional cell carcinoma. Cancer Genet Cytogenet 2003;142:25-9.
7. Vet JA, Hessels D, Marras SA, van de Kaa CA, van der Poel HG, Michalides RJ, et al. Comparative analysis of p53 mutations in bladder washings and histologic specimens. Am J Clin Pathol 1998;110:647-52.
8. -ΔΔC(T) method. Methods 2001;25:402-8.